Drugs and Devices

FDA approves nasal spray for nocturnal polyuria

On March 3, the U.S. Food and Drug Administration (FDA) approved octiva (desmopressin acetate) nasal spray for adults with nocturnal polyuria. Read more 


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares